ROCHESTER, N.Y., June 16, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational firm working companies specializing in model safety expertise, blockchain safety, direct advertising, healthcare, client packaging, actual property, renewable vitality, and securitized digital property, as we speak introduced its wholly owned subsidiary Impact BioMedical, Inc. (“Impact BioMedical”) acquired discover of issuance (US 10,966,424) from the U.S. Patent and Trademark Office (“USPTO”) for 3FDB, a Functional Fragrance Formulation (3F) expertise that will increase the effectiveness of present mosquito repellants by means of a delightfully aromatic compound derived from botanical oils. 3FDB is an efficacy booster for present mosquito repellants akin to DEET, Picaridin, and IR3535, amongst others. The booster incapacitates two of the three receptors that mosquitos use to search out sources of vitamin, on this case, that supply is people. “While present mosquito repellants goal solely the gustatory receptors in bugs, 3FDB makes use of a a number of receptor method by concentrating on ionotropic, gustatory and olfactory receptors in bugs to offer a synergistic motion to repel bugs in addition to inhibit the power of bugs to detect and search prey,” says Daryl Thompson, Director of Scientific Initiatives at Impact BioMedical and founding father of superior analysis firm GRDG Sciences, LLC (“GRDG”). While 3FDB has far-reaching purposes for on a regular basis life, a very powerful software might be saving lives. According to the National Institutes of Health, mosquitos are accountable for greater than one million deaths every year as a result of they will host a wide range of ailments together with malaria, dengue, West Nile yellow fever, Zika, chikungunya, and lymphatic filariasis. Impact BioMedical’s Chief Scientific Advisor Dr. Roscoe M. Moore, Jr., United States Assistant Surgeon General (Retired) and former Epidemic Intelligence Service (EIS) Officer at U.S. Centers for Disease Control and Prevention, mentioned, “This patent may pave the way in which for elevated safety from mosquito-borne ailments world wide.” The need to save lots of lives was the impetus that led Impact BioMedical to hunt an answer to this international well being drawback. The Florida-based workforce discovered it proper in their very own yard. How It Was FoundImpact BioMedical discovered its resolution to minimizing mosquito bites in orchids — particularly the elusive and legendary ghost orchid flower — discovered solely within the wild in Cuba and the Florida Everglades. “We checked out over 300 uncommon orchids from world wide — from Borneo to the Congo to South and Central America — in addition to our personal Florida Everglades,” mentioned Thompson. “We noticed that whereas the mosquitos had been plentiful in these environments, not one of the males had been ever drawn to or pollinating the orchids. The orchids had been principally invisible to the mosquitos.” The workforce theorized that the orchids had been producing a chemical that inhibited the mosquitos’ capability to search out them. Through testing and analysis, the workforce recognized the chemical compounds then labored backwards to discover a solution to isolate and reproduce them. “3FDB works in a different way from conventional insect repellents. It’s efficient even at very low concentrations as a result of its multi-aspect receptor inhibition,” mentioned Thompson. How It WorksMosquitos have a trio of receptors — ionotropic, gustatory, and olfactory — that detect the chemical substances and carbon dioxide people expel by means of perspiration and respiration. Existing mosquito repellents focus primarily on the gustatory receptor, which diminishes the mosquito’s capability to detect people, however nonetheless leaves the opposite two receptors — ionotropic and olfactory — lively. 3FDB, utilizing the replicated chemical compounds discovered within the ghost orchid, focuses on the opposite two receptors, and gives additional safety for the third. The booster blocks the insect’s capability to detect people, primarily making people invisible to the mosquito. “We are continuously pushing to remain forward of points affecting the world and look for methods to offer secure and significant options to fight these issues,” mentioned Mr. Chan Heng Fai, Chairman of DSS. Long-Term FunctionsThe workforce relied on the experience of its companions at Chemia Corporation to make use of the chemical compounds of the orchid as the bottom for 3FDB’s deliberately mild and nice scent. “This collaboration has confirmed the ability of analysis, and perfume is a brand new frontier in revolutionary expertise,” mentioned Thomas A. Meyer, Vice President, Innovation and Sustainability, Chemia Corporation. 3FDB will be included in a wide range of purposes, akin to sprays, lotions, laundry detergents, shampoos, soaps, material softeners, dryer sheets, misters, air flow techniques, and air fresheners. According to Statista, the US market for mosquito repellants is forecasted to be $860 million in 2021, rising to $1.2 billion by 2025. Globally, the market is predicted to surpass $6 billion by 2027. “We are happy with the latest situation of our 3F composition patent for a pure insect repellent,” mentioned Frank Heuszel, CEO of DSS and President of Impact BioMedical. “There is important curiosity in repellents from botanical sources, and this achievement demonstrates our intent to make these distinctive merchandise accessible to customers worldwide sooner or later.” About Impact BioMedical, Inc.Impact BioMedical, Inc. (“Impact BioMedical”) is an entirely owned subsidiary of DSS and a singular expertise supply, developer, and enterprise companion in addressing unmet wants in human healthcare and wellness. For extra data on Impact BioMedical go to http://impbio.com/. About Document Security Systems, Inc.DSS is a multinational firm working companies centered on model safety expertise, blockchain safety, direct advertising, healthcare, client packaging, actual property, renewable vitality, and securitized digital property. Its enterprise mannequin relies on a distribution sharing system through which shareholders will obtain shares in its subsidiaries as DSS strategically spins them out into IPOs. Its historic enterprise revolves round counterfeit deterrent and authentication applied sciences, sensible packaging, and client product engagement. DSS is led by its Chairman and largest shareholder, Mr. Fai Chan, a extremely profitable international enterprise veteran of greater than 40 years specializing in company transformation whereas managing danger. He has efficiently restructured greater than 35 firms with a mixed worth of $25 billion. For extra data on DSS go to http://www.dsssecure.com. Investor Contact:Dave Gentry, CEORedChip Companies [email protected] Safe Harbor DisclosureThis press launch incorporates forward-looking statements which might be made pursuant to the secure harbor provisions throughout the that means of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements embody, however usually are not restricted to, statements associated to the Company’s capability to finish the financing, its supposed use of proceeds and different statements that aren’t historic details. Forward-looking statements are based mostly on administration’s present expectations and are topic to dangers and uncertainties which will trigger precise outcomes or occasions to vary materially from these projected. These dangers and uncertainties, a lot of that are past our management, embody: the chance that the general public providing of widespread inventory could not shut; dangers regarding our progress technique; our capability to acquire, carry out underneath and preserve financing and strategic agreements and relationships; dangers regarding the outcomes of improvement actions; our capability to draw, combine and retain key personnel; our want for substantial further funds; patent and mental property issues; competitors; in addition to different dangers described within the part entitled “Risk Factors” within the prospectus and in our different filings with the SEC, together with, with out limitation, our stories on Forms 8-Okay and 10-Q, all of which will be obtained on the SEC web site at www.sec.gov. Readers are cautioned to not place undue reliance on the forward-looking statements, which communicate solely as of the date on which they’re made and mirror administration’s present estimates, projections, expectations and beliefs. We expressly disclaim any obligation or enterprise to launch publicly any updates or revisions to any forward-looking statements contained herein to mirror any change in our expectations or any adjustments in occasions, circumstances or circumstances on which any such assertion relies, besides as required by regulation.